The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity

Susanne U. Trost, Eric Swanson, Bernd Gloss, David B. Wang-Iverson, Hongjiang Zhang, Tanya Volodarsky, Gary J. Grover, John D. Baxter, Grazia Chiellini, Thomas (Tom) Scanlan, Wolfgang H. Dillmann

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

Thyroid hormones influence the function of many organs and mediate their diverse actions through two types of thyroid hormone receptors, TRα and TRβ. Little is known about effects of ligands that preferentially interact with the two different TR subtypes. In the current study the comparison of the effects of the novel synthetic TRβ-selective compound GC-1 with T3 at equimolar doses in hypothyroid mice revealed that GC-1 had better triglyceride-lowering and similar cholesterol-lowering effects than T3. T3, but not GC-1, increased heart rate and elevated messenger RNA levels coding for the It channel (HCN2), a cardiac pacemaker that was decreased in hypothyroid mice. T3 had a larger positive inotropic effect than GC-1. T3, but not GC-1, normalized heart and body weights and messenger RNAs of myosin heavy chain α and β and the sarcoplasmic reticulum adenosine triphosphatase (Serca2). Additional dose-response studies in hypercholesteremic rats confirmed the preferential effect of GC-1 on TRβ-mediated parameters by showing a much higher potency to influence cholesterol and TSH than heart rate. The preferred accumulation of GC-1 in the liver vs. the heart probably also contributes to its marked lipid-lowering effect vs. the absent effect on heart rate. These data indicate that GC-1 could represent a prototype for new drugs for the treatment of high lipid levels or obesity.

Original languageEnglish (US)
Pages (from-to)3057-3064
Number of pages8
JournalEndocrinology
Volume141
Issue number9
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Thyroid Hormone Receptors
Hormones
Lipids
Heart Rate
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
Cholesterol
Messenger RNA
Myosin Heavy Chains
GC 1 compound
Sarcoplasmic Reticulum
Thyroid Hormones
Adenosine Triphosphatases
Triglycerides
Obesity
Body Weight
Ligands
Liver

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Trost, S. U., Swanson, E., Gloss, B., Wang-Iverson, D. B., Zhang, H., Volodarsky, T., ... Dillmann, W. H. (2000). The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology, 141(9), 3057-3064. https://doi.org/10.1210/en.141.9.3057

The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. / Trost, Susanne U.; Swanson, Eric; Gloss, Bernd; Wang-Iverson, David B.; Zhang, Hongjiang; Volodarsky, Tanya; Grover, Gary J.; Baxter, John D.; Chiellini, Grazia; Scanlan, Thomas (Tom); Dillmann, Wolfgang H.

In: Endocrinology, Vol. 141, No. 9, 2000, p. 3057-3064.

Research output: Contribution to journalArticle

Trost, SU, Swanson, E, Gloss, B, Wang-Iverson, DB, Zhang, H, Volodarsky, T, Grover, GJ, Baxter, JD, Chiellini, G, Scanlan, TT & Dillmann, WH 2000, 'The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity', Endocrinology, vol. 141, no. 9, pp. 3057-3064. https://doi.org/10.1210/en.141.9.3057
Trost, Susanne U. ; Swanson, Eric ; Gloss, Bernd ; Wang-Iverson, David B. ; Zhang, Hongjiang ; Volodarsky, Tanya ; Grover, Gary J. ; Baxter, John D. ; Chiellini, Grazia ; Scanlan, Thomas (Tom) ; Dillmann, Wolfgang H. / The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. In: Endocrinology. 2000 ; Vol. 141, No. 9. pp. 3057-3064.
@article{89f9a0be98ca4338a7810cca13489856,
title = "The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity",
abstract = "Thyroid hormones influence the function of many organs and mediate their diverse actions through two types of thyroid hormone receptors, TRα and TRβ. Little is known about effects of ligands that preferentially interact with the two different TR subtypes. In the current study the comparison of the effects of the novel synthetic TRβ-selective compound GC-1 with T3 at equimolar doses in hypothyroid mice revealed that GC-1 had better triglyceride-lowering and similar cholesterol-lowering effects than T3. T3, but not GC-1, increased heart rate and elevated messenger RNA levels coding for the It channel (HCN2), a cardiac pacemaker that was decreased in hypothyroid mice. T3 had a larger positive inotropic effect than GC-1. T3, but not GC-1, normalized heart and body weights and messenger RNAs of myosin heavy chain α and β and the sarcoplasmic reticulum adenosine triphosphatase (Serca2). Additional dose-response studies in hypercholesteremic rats confirmed the preferential effect of GC-1 on TRβ-mediated parameters by showing a much higher potency to influence cholesterol and TSH than heart rate. The preferred accumulation of GC-1 in the liver vs. the heart probably also contributes to its marked lipid-lowering effect vs. the absent effect on heart rate. These data indicate that GC-1 could represent a prototype for new drugs for the treatment of high lipid levels or obesity.",
author = "Trost, {Susanne U.} and Eric Swanson and Bernd Gloss and Wang-Iverson, {David B.} and Hongjiang Zhang and Tanya Volodarsky and Grover, {Gary J.} and Baxter, {John D.} and Grazia Chiellini and Scanlan, {Thomas (Tom)} and Dillmann, {Wolfgang H.}",
year = "2000",
doi = "10.1210/en.141.9.3057",
language = "English (US)",
volume = "141",
pages = "3057--3064",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity

AU - Trost, Susanne U.

AU - Swanson, Eric

AU - Gloss, Bernd

AU - Wang-Iverson, David B.

AU - Zhang, Hongjiang

AU - Volodarsky, Tanya

AU - Grover, Gary J.

AU - Baxter, John D.

AU - Chiellini, Grazia

AU - Scanlan, Thomas (Tom)

AU - Dillmann, Wolfgang H.

PY - 2000

Y1 - 2000

N2 - Thyroid hormones influence the function of many organs and mediate their diverse actions through two types of thyroid hormone receptors, TRα and TRβ. Little is known about effects of ligands that preferentially interact with the two different TR subtypes. In the current study the comparison of the effects of the novel synthetic TRβ-selective compound GC-1 with T3 at equimolar doses in hypothyroid mice revealed that GC-1 had better triglyceride-lowering and similar cholesterol-lowering effects than T3. T3, but not GC-1, increased heart rate and elevated messenger RNA levels coding for the It channel (HCN2), a cardiac pacemaker that was decreased in hypothyroid mice. T3 had a larger positive inotropic effect than GC-1. T3, but not GC-1, normalized heart and body weights and messenger RNAs of myosin heavy chain α and β and the sarcoplasmic reticulum adenosine triphosphatase (Serca2). Additional dose-response studies in hypercholesteremic rats confirmed the preferential effect of GC-1 on TRβ-mediated parameters by showing a much higher potency to influence cholesterol and TSH than heart rate. The preferred accumulation of GC-1 in the liver vs. the heart probably also contributes to its marked lipid-lowering effect vs. the absent effect on heart rate. These data indicate that GC-1 could represent a prototype for new drugs for the treatment of high lipid levels or obesity.

AB - Thyroid hormones influence the function of many organs and mediate their diverse actions through two types of thyroid hormone receptors, TRα and TRβ. Little is known about effects of ligands that preferentially interact with the two different TR subtypes. In the current study the comparison of the effects of the novel synthetic TRβ-selective compound GC-1 with T3 at equimolar doses in hypothyroid mice revealed that GC-1 had better triglyceride-lowering and similar cholesterol-lowering effects than T3. T3, but not GC-1, increased heart rate and elevated messenger RNA levels coding for the It channel (HCN2), a cardiac pacemaker that was decreased in hypothyroid mice. T3 had a larger positive inotropic effect than GC-1. T3, but not GC-1, normalized heart and body weights and messenger RNAs of myosin heavy chain α and β and the sarcoplasmic reticulum adenosine triphosphatase (Serca2). Additional dose-response studies in hypercholesteremic rats confirmed the preferential effect of GC-1 on TRβ-mediated parameters by showing a much higher potency to influence cholesterol and TSH than heart rate. The preferred accumulation of GC-1 in the liver vs. the heart probably also contributes to its marked lipid-lowering effect vs. the absent effect on heart rate. These data indicate that GC-1 could represent a prototype for new drugs for the treatment of high lipid levels or obesity.

UR - http://www.scopus.com/inward/record.url?scp=17744387900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744387900&partnerID=8YFLogxK

U2 - 10.1210/en.141.9.3057

DO - 10.1210/en.141.9.3057

M3 - Article

C2 - 10965874

AN - SCOPUS:17744387900

VL - 141

SP - 3057

EP - 3064

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -